Enliven Therapeutics, Inc. (ELVN)
27.20
+0.16
(+0.57%)
USD |
NASDAQ |
Jan 21, 16:00
27.20
0.00 (0.00%)
Pre-Market: 08:33
Enliven Therapeutics Market Cap: 1.615B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Coherus Oncology, Inc. | 198.23M |
| Allogene Therapeutics, Inc. | 359.57M |
| Pyxis Oncology, Inc. | 103.36M |
| CEL-SCI Corp. | 15.96M |
| AIM ImmunoTech, Inc. | 3.442M |
Market Cap Related Metrics
| Price to Book Value | 3.391 |
| Price | 27.20 |
| Earnings Yield | -6.79% |